Mesothelioma News – treatments, cure, research, and more
The Netherlands – A research study led by Dr. Paul Baas of the Netherlands Cancer Institute has found that the drug Thalidomide does not slow the progression of malignant pleural mesothelioma nor does it improve the survival rate of those suffering from the disease.
The study, which was a collaboration between the Dutch and Australians, hoped to establish whether the inclusion of an anti-vascular agent, like thalidomide, as part of the treatment for asbestos cancer patients would slow or halt tumor growth, reports Dr. Baas.
A recent news article highlighted the story of a man recently diagnosed with mesothelioma. According to reports, he has received a considerably large payout from his former employer. The former 82-year-old union official was diagnosed with mesothelioma, a cancer of the lining of the lungs that can take decades to develop. Mesothelioma is a terminal cancer and is only caused by exposure to asbestos, commonly in the workplace. There currently is no cure.
Do you like this article?
Info: Information in this webpage is for educational purposes only. It is not intended as a substitute for the diagnosis, treatment and advice of a qualified licensed medical professional. This site offers people medical information on mesothelioma but in no way should anyone consider that this site represents the "practice of medicine." This site assumes no responsibility for how this material is used. Also note that this webpage frequently updates its contents, due to a variety of reasons, therefore, some information may be out of date.